Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

AIMS/HYPOTHESIS: An increased risk of fracture with canagliflozin vs placebo was reported from the CANagliflozin cardioVascular Assessment Study (CANVAS) Program, with heterogeneity of findings identified between the two trials that comprise the CANVAS Program, CANVAS and CANVAS-R. The objective of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetologia
Huvudupphovsmän: Zhou, Zien, Jardine, Meg, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Desai, Mehul, Oh, Richard, Simpson, Roger, Watts, Nelson B., Neal, Bruce
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731200/
https://ncbi.nlm.nih.gov/pubmed/31399845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-019-4955-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk